Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A W Schmidt

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Proceedings of the National Academy of Sciences of the United States of America|September 17, 1996
CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptorsD W Schulz, R S Mansbach, J Sprouse, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
Characterization of CP-122,721; a nonpeptide antagonist of the neurokinin NK1 receptorS McLean, A Ganong, P A Seymour, et al.
Journal of Medicinal Chemistry|January 23, 2004
Design, synthesis, and evaluation of metabolism-based analogues of haloperidol incapable of forming MPP+-like speciesM Lyles-Eggleston, R Altundas, J Xia, et al.
Journal of Medicinal Chemistry|January 5, 1996
3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agentsH R Howard, J A Lowe, T F Seeger, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Proceedings of the National Academy of Sciences of the United States of America|September 17, 1996
CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptorsD W Schulz, R S Mansbach, J Sprouse, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
Characterization of CP-122,721; a nonpeptide antagonist of the neurokinin NK1 receptorS McLean, A Ganong, P A Seymour, et al.
Journal of Medicinal Chemistry|January 23, 2004
Design, synthesis, and evaluation of metabolism-based analogues of haloperidol incapable of forming MPP+-like speciesM Lyles-Eggleston, R Altundas, J Xia, et al.
Journal of Medicinal Chemistry|January 5, 1996
3-Benzisothiazolylpiperazine derivatives as potential atypical antipsychotic agentsH R Howard, J A Lowe, T F Seeger, et al.
Pageof 4